September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
Lesion size measurement using optical coherence tomography in polypoidal choroidal vasculopathy
Author Affiliations & Notes
  • Machiko Kimura
    Tokyo Women`s medical university, Shinjyukuku, Japan
  • Ichiro Maruko
    Tokyo Women`s medical university, Shinjyukuku, Japan
  • Moeko Kawai
    Tokyo Women`s medical university, Shinjyukuku, Japan
  • Hideki Koizumi
    Tokyo Women`s medical university, Shinjyukuku, Japan
  • Yukinori Sugano
    Fukushima medical university, Fukushimashi, Japan
  • Takeshi Muraki
    Tokyo Women`s medical university, Shinjyukuku, Japan
  • Hisaya Arakawa
    Tokyo Women`s medical university, Shinjyukuku, Japan
  • Tetsuju Sekiryu
    Fukushima medical university, Fukushimashi, Japan
  • Tomohiro Iida
    Tokyo Women`s medical university, Shinjyukuku, Japan
  • Footnotes
    Commercial Relationships   Machiko Kimura, None; Ichiro Maruko, None; Moeko Kawai, None; Hideki Koizumi, None; Yukinori Sugano, None; Takeshi Muraki, None; Hisaya Arakawa, None; Tetsuju Sekiryu, None; Tomohiro Iida, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science September 2016, Vol.57, 2170. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Machiko Kimura, Ichiro Maruko, Moeko Kawai, Hideki Koizumi, Yukinori Sugano, Takeshi Muraki, Hisaya Arakawa, Tetsuju Sekiryu, Tomohiro Iida; Lesion size measurement using optical coherence tomography in polypoidal choroidal vasculopathy. Invest. Ophthalmol. Vis. Sci. 2016;57(12):2170.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Photodynamic therapy (PDT) is one of the treatment of polypoidal choroidal vasculopathy (PCV) because of polypoidal regression. PDT needs to measure the greatest linear dimension (GLD) after fluorescein angiography and/or indocyanine green angiography (IA). In the current study, we measured the pathological lesion size (LS) and GLD using optical coherence tomography (OCT) for non-invasive approach.

Methods : Fifteen eyes of 15 patients (11 men, 4 women, and average 73 year-old) with PCV was examined. All eyes were examined by IA and OCT (DRI-OCT, Topcon) in Tokyo Women’s Medical University or Fukushima Medical University. GLD and LS were measured in IA images (IA-GLD and IA-LS). The measurement of GLD using IA was referred to the report by Otani et al (AJO 2007). GLD and LS based in OCT (OCT-GLD and OCT-LS) were measured by the irregular area of retinal pigment epithelium (RPE) in en-face OCT images using the open source image analysis software (ImageJ). Reliability of all results were evaluated by the interclass correlation coefficient (ICC).

Results : Mean LS was 3.54 ±1.66 mm2 in IA-LS and 4.40 ±2.47 mm2 in OCT-LS, respectively. Mean GLD was 2825 ±675 μm in IA-GLD and 2984±971 μm in OCT-GLD, respectively. ICC between IA and OCT were 0.61 in LS and 0.83 in GLD (both p<0.01).

Conclusions : GLD was correlated more than LS. OCT can measure the GLD for PDT, however it is not enough to measure the RPE irregularity in OCT for the evaluation of the exact exudative area.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×